CAR T-Cell Therapy: A Path of Hope and Healing

The Leukemia & Lymphoma Society (LLS) has launched a new docuseries to inform blood cancer patients, caregivers, healthcare providers, and the public about the revolutionary progress of CAR T-cell therapy. 

Through an array of emotional patient stories and an interview with immunologist and oncologist Carl June, M.D., of Penn Medicine, this 3-part mini-series aims to educate the public about the treatment advances in blood cancer, in particular CAR-T and other cell therapies.

Dr. June helped pioneer CAR T-cell therapy with LLS research funding support.

Speakers

Carl June, MD
Cancer Researcher & CAR T-cell Therapy Pioneer
Richard W. Vague Professor in Immunotherapy
Professor of Medicine
Director, Center for Cellular Immunotherapies
Director, Parker Institute for Cancer Immunotherapy
University of Pennsylvania Perelman School of Medicine

Maurice
Multiple Myeloma Patient

Tim 
Diffuse Large B-Cell Lymphoma
CAR T-Cell Therapy Patient

Supporters

Support provided by Kite, a Gilead Company; Bristol Myers Squibb; Johnson & Johnson and Legend Biotech.